# BEVESPI AEROSPHERE

NDC: 0310-4600
Generic name: Glycopyrrolate and formoterol fumarate
Labeler / Manufacturer: AstraZeneca Pharmaceuticals LP
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: AEROSOL, METERED
Routes: RESPIRATORY (INHALATION)
Marketing started: 20161003

FDA application: NDA208294

## Active ingredients

- FORMOTEROL FUMARATE: 4.8 ug/1
- GLYCOPYRROLATE: 9 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0310-4600"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0310-4600
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ae02436e-9528-490e-a844-0c0f6f2843f9